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INTELLECTUAL PROPERTY RIGHTS AS A
TRADE, HEALTH AND ECONOMIC
DEVELOPMENT ISSUE
BRUCE A. LEHMAN*
I actually intend in my own discussions to address a narrower
issue than the T.R.I.P.S. agreement, but having heard the two
previous speakers, I think before I get into my topic of interest, I
would first like to just take the opportunity to make some
observations about the two previous presentations. Actually, the
need to make these observations probably is not that great since
at the end of Professor Thomas' remarks and also in Peter
Fowler's remarks you heard the answers to some of the questions
that were given by Professor Damas, but I want to emphasize my
view on a couple of them.
First of all, with regard to the T.R.I.P.S. Agreement', the
T.R.I.P.S. Agreement was an agreement that was negotiated on
the basis of quid pro quos among states. Each state gave
something and got something. Developing countries and
developed countries each had parochial issues, parochial trade,
and industrial concerns of interest to them that were important
to them in the Uruguay round.2 In some cases that was a
protectionist agenda, in some cases that was an export-oriented
' Bruce A. Lehman served from 1993 through 1998 as United States Assistant Secretary
of Commerce and Commissioner of Patents and Trademarks in the Clinton
Administration. Currently, he is president of the International Intellectual Property
Institute (IIPI) which works with developing countries to harness their citizens'
intellectual property as a source of economic growth. More on IIPI can be found at
www.iipi.org.
I See Agreement on Trade-Related Aspects of Intellectual Property Rights, Dec. 15,
1993, Annex IC, 33 I.L.M. 81 [hereinafter TRIPS] (establishing multilateral agreement
creating minimum protection standards for protecting various forms of intellectual
property among nations).
2 See Final Act Embodying the Results of the Uruguay Round of Trade Negotiations,
Dec. 15, 1993, 33 I.L.M. 1 (establishing the World Trade Organization (WTO) in the last
round of GATT and also creating treaties covering services, intellectual property rights
and investment matters).
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agenda where they wanted access to other markets. The WTO
agreement 3 is about market access fundamentally and that is one
of the reasons that I think the T.R.I.P.S. Agreement could have
come about in the first place. We have long had the World
Intellectual Property Organization, 4 and as Professor Thomas
pointed out, the intellectual property agreements are some of the
oldest international law that there is. We, for quite a few years,
have discussed agenda items like compulsory licensing or
geographic indications in the context of amendments to the Paris
Convention 5 or the Berne Convention, 6 but it was very, very
difficult to tackle difficult issues like these because the context in
which WIPO treaties are negotiated is basically just an open
forum. A lot like this room with 160 different countries sitting
here and everybody putting forth their own ideas, and there is
not any glue; there is not really any pressure that causes them or
forces them to come together upon something. As a result, a
number of very significant international agreements like the
Rome Convention, 7 never included key players like the United
States. As a result, only some countries adhere to the Rome
Convention and recognize the neighboring intellectual property
rights therein included. Similarly, there are treaties that the
United States has proposed that other countries have never
really signed up to. So, even where you can get agreement
among negotiating countries in principle, it is really difficult to
build a treaty unless a country has some very compelling reason
to adhere to the agreement and to disregard what almost in
every case, whether it is this country or any other, are going to be
very significant domestic interests they are not going to want in
the agreement. The underlying message here about the T.R.I.P.S.
3 See Multilateral Trade Negotiations Final Act Embodying the Results of the
Uruguay Round of Trade Negotiations, Apr. 15, 1994, 33 I.L.M. 1125 [hereinafter WTO
agreement] (creating World Trade Organization).
4 See The World Intellectual Property Organization, at http://www.wipo.org. (last
visited Apr. 12, 2003).
5 Paris Convention for the Protection of Industrial Property, Mar.20, 1883, 21 U.S.T.
1583 (last revised July 14, 1967) [hereinafter Paris Convention] (creating WIPO and
enacting regulations promoting industrial property).
6 Berne Convention for Protection of Literary and Artistic Works, Sept. 9, 1886, 282
U.S.T. 1583 [hereinafter Berne Convention] (establishing multilateral treaty composes of
nations "for the protection of the rights of authors in their literary and artistic works").
7 See Luca G. Radicati Di Brozolo, International Payments and Conflicts of Laws, 48




Agreement is that one has to view it in the WTO context. The
many agreements concluded under the WTO framework brought
many benefits to developing countries, particularly market
access. The next time you are shopping at the mall, walk into any
apparel store and look on the tag on where the product was
made, I think nine times out of ten today you will find that it was
not made in the United States and it was not probably made in
some other developed country: it was made in a developing
country. Back when the Uruguay Round was first getting
underway that was not necessarily the case. Clearly participation
in the Uruguay Round brought developing countries greater
access to developed country markets for their products. That was
the principle trade-off and in return we had to get something,
and what we got in T.R.I.P.S. was recognition of the value of the
intangibles that are the heart of a modern post-industrial
economy.
The United States has not even remotely recognized the
benefits of T.R.I.P.S. yet, and I also want to point out that
T.R.I.P.S. by no means is restricted to patents. Probably the
greatest beneficiaries by far of the T.R.I.P.S. Agreement are the
information industries. The computer software industry,
Hollywood, the sound recording industry and so on, which have
used T.R.I.P.S. to capture markets which were previously
dominated by piracy.8 I should add TRIPS has been applied to
protect United States interests in developed countries like Italy
where we have reduced piracy rates for computer software for
example, by using the principles of the T.R.I.P.S. Agreement. 9
Now before I get again into my talk, I want to make one other
observation concerning the AIDS issue in Africa because it is
incredibly interesting to me and because the debate greatly
frustrates me.
I think AIDS activists have done a huge disservice to the
problem of providing relief to people in the developing world by
8 See Nuno Pires De Carvalho, International and Comparative Law Issues: Requiring
the Disclosure of the Origin of Genetic Resources and Prior Informed Consent in Patent
Applications Without Infringing The TRIPS Agreement: The Problem and The Solution, 2
WASH. U.J.L. & POLY 371, 375-400 (2000) (detailing the strengths and weaknesses of the
TRIPS Agreement).
9 See also Marian Nash, Contemporary Practice of the United States Relating To
International Law, 92 AMER.J.INT'L L 44, 56 (1998) (stating that the TRIPS Agreement
does protect computer software as literary works).
2003]
420 ST JOHN'S JO URNAL OF LEGAL COMMENTARY
directing a disproportionate focus on the patent issue. My
organization, IIPI,10 has been extensively involved in this issue
and we have two documents worth viewing on the matter. You
will be referred to them if you look at our website, which is
www.iipi.org. The first was a study in 2000, which is also
available on the website of the WIPO, www.wipo.int, where we
actually looked at the patent status of AIDS drugs in African
countries and found that by and large these pharmaceuticals had
never even been patented in most African countries."1 That
research was updated in an article by my South African
colleague, Lee Gillespie-White, at IIPI, and Amir Attaran of
Harvard University, in the Journal of the American Medical
Association in October 2001.12 Both of these studies really point
out that the problem is not patents in most cases.13 The problem
simply is that there is a market breakdown.14 The fact is that
AIDS drugs under any scenario cost money and that the
infrastructure to deliver them to patients cost money, and that in
many of these countries the economic foundation to sustain these
costs simply does not exist.
Now Brazil is a country that has been much in the news as a
successful developing country in dealing with the issue of AIDS. 15
I would first like to point out that Brazil is a pretty wealthy
developing country. I think it has about an $8,000 a year per
capita income, maybe $8,900 now. 16 It also has a small AIDS
10 See International Intellectual Property Institute, at http://www.iipi.org (last
visited Apr. 12, 2003) (detailing the operations of the organization).
11 See World Intellectual Property Organization, Patent Protection and Access to
HIVAIDS Pharmaceuticals in Sub-Saharan Africa, at http://www.wipo.int/news/en (last
visited Feb. 21, 2003) (discussing IIPI's HIV/AIDS study and findings).
12 See Amir Attaran & Lee Gillespie-White, Do Patents for Antiretroviral Drugs
Constrain Access to AIDS Treatment in Africa?, 286 JOURNAL OF AM. MED. ASS'N 1803,
Oct. 17, 2001, available at http://jama.ama-assn.orglissues/v286n15/ffull/jsclO222.html
(last visited Feb. 21, 2003) (questioning whether patents restrict access to AIDS
treatment in Africa).
13 Id. (stating "patents generally do not appear to be a substantial barrier to
antiretroviral treatment access in Africa today").
14 Id. (finding that "the extreme dearth, rather than the patents, is the most to blame
for the lack of antiretroviral treatment in Africa").
15 See Larry Rother, Departing President Leaves a Stable Brazil, N.Y. TIMES, Dec.
29, 2002, at 1-10 (noting that AIDS-related deaths in Brazil had been reduced by two-
thirds).
16 See e.g., The World Bank Group, Country Classifications, available at
http://www.worldbank.org/data/countryclass/classgroups.htm (last visited Apr. 12, 2003)
(labeling Brazil as an upper middle income economy).
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population of about 100,000.17 But the Brazil program still costs
$4,000 a year for each of those 100,000 people.IS So that is
equals an enormous cost if you were to translate that into
30,000,000 people or more in Africa that are affected by AIDS.
You can see that the magnitude of those costs simply is
unsustainable given the economy of Africa, even under the most
liberal intellectual property regime or even the use of generic
products. Now one of the things that really inflames me more
than anything else about AIDS activists is when they talk about
the issue of parallel importation as a solution to the problem and
when they oppose national exhaustion of patent rights in the
AIDS crisis. 19 Nothing could be worse for dealing with the AIDS
problem. If you had assumed the principle of international
exhaustion, that is you can shop anywhere in the world that you
want and look for the cheapest price for AIDS drugs, do you
think that South Africa, if they gobbled every single product on
the market would even come close to being able to satisfy their
domestic need? Of course they would not. In fact, the issue
should be looked at from the opposite point of view. What has to
happen is that national markets have to be segregated out so
that prices can be established that fit those markets. You are
never, ever going to solve the African problem at $10,000 per
capita. Drugs are going to have to be vastly cheaper, and so what
is going to have to happen is that a fence is going to have to be
put around certain countries. The issue then is less about are
they going to get cheaper drugs elsewhere, but are the cheap
drugs which are provided to them going to be kept there for their
use or whether well find them on the streets of New York in a
black market facilitated by gray market importation.
So what it really boils down to is the issue of money. I was a
loyal member of the Clinton Administration and I am very, very
proud of the work that we did, but I have to say one thing that I
am still unsettled about is the administration's approach to the
17 See Patrice M. Jones, Brazil's free AIDS-drug Program Slashes Cases, Earns
Global Interest, CHIc. TRIB., Dec. 24, 2000 (noting that only one percent of Brazil's
population is infected with HIV/AIDS).
18 Id. (stating that Brazil spends approximately $4,500 a year on each AIDS-infected
individual).
19 See John A. Harrelson, TRIPS, Pharmaceutical Patents and the HIVAIDS Crisis:
Finding the Proper Balance Between Intellectual Property Rights and Compassion, 7
WIDENER. L. SYMP. J. 175 (2001) (outlining the arguments for national exhaustion of
patent rights and parallel importation).
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AIDS problem. Professor Thomas mentioned the speech that Vice
President Gore gave at the United Nations 20 and I remember
being in the Vice President's office shortly after he had come back
from South Africa and had an awareness of the crises in Africa.
At the time I wrote a paper about the crises and sent it to his
domestic policy advisor. The paper then got sent to the National
Security Shop and I think it was put in a file.
The paper really focused on what the real problem is: a
question of money. The Clinton Administration's budget for
foreign assistance regarding the HIV disease was $250 million
globally.21 Now $250 million is not even in the ballpark for
providing any kind of real drug treatment to millions and
millions of people in Africa or elsewhere. In fact, it wasn't even
adequate really to support education programs or abstinence
programs or whatever else, condom sales, etc. This is an
administration that spent $12 billion on the war in Kosovo 22 to
deal with the concerns of a half-million press people in Kosovo,
but it could not spend any more than $250 million on AIDS. And
that is where the problem lies. Secretary General of the United
Nations, Kofi Annan, said we had to have at least a $10-billion
fund, and countries like the United States are going to have to
put up at least $3 billion. 23 I think the Bush Administration's
proposal this year is about $300 million.24 Now initially I
thought the Bush people might be actually making some progress
there. Tommy Thompson's shop was really looking into this and I
thought there was a real possibility frankly that the Bush people
might finally realize we needed more money. Frankly, after
September 11th this item has really moved down on the agenda.
20 See CNN, Gore to Announce Major Initiative on AIDS in Africa: Vice President to
Un veil Plans at United Nations, available at
http://www.cnn.com/2000/WORLD/africa/01/09/un.africa.aids.0l.htm (last visited Feb. 21,
2003) (stating that Vice President Al Gore would announce a major policy initiative
towards AIDS in Africa).
21 See AIDS Council Criticizes Clinton's Follow-Through, WASH. POST, Dec.20, 1998,
at A27 (noting that President Clinton's AIDS advisory council criticized budget cuts in
AIDS research).
22 See Military Construction, WASH. POST, May 21, 2000, at M13 (noting that $4.1
billion had been earmarked for operations in Kosovo in the year 2000).
23 See Paul Blustein, Bush to Announce Three-Year Spending Initiative $500 Million
Set for Global Push to Fifght Transmission to Infants, WASH. POST, June 19, 2002, at A03
(stating Kofi Annan's desire for $10 billion dollar a year international funding for the
prevention of AIDS).




The blame is not only in Washington and I think Professor
Thomas also pointed out the blame is also in capitals of many of
these affected countries where there is a real denial on the part
of the leadership that they have a problem at all. Heads of State
are coming into Washington day and night practically from all
parts of the world to visit the President. Rarely when developing
country heads of state or heads of government come to
Washington do they ever raise the issue of assistance to their
countries on the AIDS question. And one of the leading examples
of that is South Africa where the Chief of State has denied that
HIV even causes AIDS, as Professor Thomas pointed out.25 I
have been in South Africa twice in the last six months, and
interestingly that is a very unpopular position, and what has
happened now is that provincial governments in South Africa are
recognizing there is a problem and they are beginning to provide
anti-retroviral drugs to patients in the public health system, and
pharmaceutical companies are providing those products at
discounted prices.
So to try to suggest that the big bad pharmaceutical companies
are the source of the problem is really doing a disservice to the
millions of people who desperately need these therapies.
With all that said, I now have only about five minutes left for
my real talk, which is thankfully written up in the materials.
After I left the Clinton Administration I felt very much obligated
to try to do something about helping developing countries
actually be able to use the benefits of TRIPS and the benefits of
intellectual property rights for their own development. To me it
is self-evident that the wealth of the world today and in the
future is in creations of the human mind. It is not in sweatshops
and it is not in increasingly lowly valued commodities. There is
not a commodity product in the world whose absolute value has
risen in the last twelve years across the board; the commodities
that developing countries have to sell are not even remotely
capable of sustaining economic growth and meeting the needs of
their population. And all you have to do I think is go down to the
maquiladora factories of Mexico where a lot of manufacturing is
going on and ask if you would like American workers to live and
25 See Aids in South Africa, THE TIMES (London), Jan. 18, 2003, at 25 (noting South
Africa's Chief of State denied the causal link between HIV and AIDS).
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work in those conditions. That is not what we call the road to
becoming a developed OECD26 member country.
So these countries have to begin making greater use of modern
institutional and legal tools to channel their intellectual
resources into productive industries that can reshape their
economy so that they can compete in the global environment.
Developing countries certainly are not lacking in the brainpower
to build the knowledge-based industries at the forefront of
economic growth. Silicon Valley would be hard pressed to
function today without bringing in software engineers from
developing countries. And in fact one of the major legislative
priorities of the business software alliance, in the last congress
was HIB Visa authority, so that they could meet their labor
shortages by bringing in from all over the world scientists and
engineers, which we weren't producing in sufficient numbers
here in the United States.27
So clearly the talent exists, but just as clearly that talent is not
being exploited back home. Instead, many countries are content
with their children working in sweatshops and their PhD
scientists living in Seattle. This is a problem that needs to be
addressed.
I have some statistics that I want and I wish I had time to do a
PowerPoint and put them up on the screen. But I think these
statistics tell the whole story and what the real nature of the
problem is. Here it would be a little more complicated situation
talking about copyrights, but let's talk about patents and the law
of technology, and clearly computer software, computer
inventions, biotech inventions, etc., are all patentable subject
matter.
There is one principle source of data concerning who uses the
global patent system. The World Intellectual Property
Organization publishes, and it is available on its website, an
annual report of patent statistics.28 This report gives patent
26 See Ben Wattenberg, Don't Wobble on Immigration, WASH. POST, Mar. 30, 2002, at
A17 (noting that Mexico is a member of the OECD).
27 Donald W. Smith, Defense of Export Control Enforcement Actions, in COPING WITH
U.S. EXPORT CONTROLS 2002, at 807, 1159-62 (PLI Com. L. & Practice Course, Handbook
Series No.844, 2002) (discussing high amount of Hi B visas for foreigners to work in
"advanced electronics").
28 World Trade Organization, WIPO Industrial Property Statistics, available at
http://www.wipo.org/ipstats/en/publicationsbindex.htm. (last visited Feb. 21, 2003)
(allowing searches of all WIPO statistics since 1994).
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filings in every patent office, for every country in the world, and
gives the number of people who are granted patents, and it
identifies which of those are foreign nationals and which are
domestic applicants. Those are patent applications filed in
national offices, and then the World Intellectual Property
Organization also administers a multi-national filing system
called a patent cooperation treaty in which you can in one single
filing apply for patents in many countries of the world. So if I am
IBM and I am filing an application at the USPTO I can say I also
want protection in Germany, Switzerland, Sweden, South Africa,
UK, Brazil, and so on. If you look at the statistics, the statistics
for use of the PCT are that 95.5% of all PCT applications come
from nationals of OECD member countries. 29 And if you include
China and Israel, into the mix it goes up to over 99%.30 So
roughly 1% of the world's patents come from everywhere else,
from India, from Brazil, from Argentina, from South Africa, from
countries many of which have a significant technological
capability - Malaysia, Singapore, etc.
Now what does that mean for the T.R.I.P.S. Agreement? What
does that mean for global development? I think it means that the
T.R.I.P.S. Agreement is unsustainable unless we start to have
more equity in its actual use. And this pushback that you are
seeing, which may or may not be justified in the health area, I
think is largely because the T.R.I.P.S. Agreement remains eight
years after its inception an agreement in which 99% of its use, at
least in the patent system, comes from a handful of developed
countries. That problem must be addressed, and there are two
issues that need to be addressed. One, which since my time is
almost up I won't go into it, which is somewhat complicated, but
it is that these countries lack by and large the means to
effectively examine patents, and so that problem has to be dealt
with. For example, in South Africa, there isn't an examination
system, but a de facto registration system.31 So if I am a
29 WIPO Industrial Property Statistics Publication B 2000, Part I, Table I, Patent
applications filed and patents granted, available at
http://www.wipo.intlipstats/en/publications/h/2000/pdf/pattabl.pdf (last visited April 11,
2003).
30 Id.
31 See Explanation of Terminology in the Proposal 'Toward the Development of APEC'
Japan Federation of Economic Organizations, available at
httpJ/www.keidanren.or.jpenglish/policy/poll065/term.html. (last visited Feb. 21, 2003)
(discussing countries that do undertake substantive examinations and noting that South
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pharmaceutical company or a biotech company and I file a patent
in South Africa, in effect I am just filing it and I have all of the
very extensive property rights that I would have in the United
States, but nobody has ever taken a look at my claims to really
determine whether I should have those rights in all of those
claims. That never happens in the United States.
Then of much greater importance, we need to help encourage
these countries to file patent applications. I did some work in
Jamaica two years ago and initially I was thinking that there
would be very little relevance of a patent system in Jamaica. But
I found that in the year preceding my visit that the University of
the West Indies, a technological university in Jamaica, had been
approached by foreign entities on licensing technology, which
they had under development. Had the Jamaicans patented these
inventions, they would not have been at a distinct disadvantage
when they negotiated an agreement.
But it doesn't do any good to file a patent application just in
Jamaica. Jamaicans need to build the capacity to file patent
applications in the United States and in the European Patent
Office; a very expensive process way beyond their means.32
I was in South Africa. South Africa does file more patents than
some other countries. The University of Cape Town, one of the
leading research institutions in the country has not a single
patent filing in the United States, and yet they have research
that may lead to very significant advances, including significant
advances in dealing with local health and agricultural problems.
The lack of patent filing by developing country institutions in
developed counties is a problem that has to be addressed and it
will only be addressed if the world community kicks in and
basically creates a funding mechanism for the disadvantaged to
get into the system. International aid groups like The World
Bank have yet to focus on the issue. They are providing all kinds
of infrastructure like building sewers and roads and out-of-date
steel mills. They should be looking at providing countries the
type of infrastructure necessary for their citizens to export the
Africa does not).
32 See Jamaica: Marketing U.S. Product and Services, available at
http://www.tradeport.org/ts/countries/jamaica/market.html. (last visited Feb. 21, 2003)
(discussing the lack of enforcement of IP laws in Jamaica due to overburdened courts and
police).
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products of their mind, rather than export their bodies to Silicon
Valley. And until we start to address that problem which seems
to be off the radar screen of policymakers, I think we are going to
have a very unbalanced use of the T.R.I.P.S. Agreement,
particularly in the patent area and it will remain unstable for the
duration of that unbalance.

